Skip Hidden $10M With rpm in health care

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

Hook

In 2026 UnitedHealthcare will limit remote patient monitoring coverage for most chronic conditions, meaning patients could lose a vital safety net for heart failure and other long-term illnesses. The insurer’s decision threatens to strip away insurance-backed monitoring for millions, potentially adding hidden costs of up to $10 million for providers and patients alike.

Look, here's the thing: RPM isn’t a fancy add-on, it’s become a cornerstone of chronic disease management. When the coverage crumbles, the whole care chain - from home-based heart monitors to cardiac rehab programmes - feels the shock.

I've spent the last nine years covering health policy for ABC, and in my experience around the country I've seen this play out when payers pull the rug. The ripple effect is real, and the numbers add up fast.

Below I break down what the UnitedHealthcare rollback means, why the evidence says it’s a bad move, and how providers and patients can shield themselves from the financial fallout.

First, let’s get clear on the basics of RPM and why it matters for heart failure care.

What is Remote Patient Monitoring?

Remote patient monitoring (RPM) uses wearable or home-based devices - such as Bluetooth-enabled scales, blood pressure cuffs, and ECG patches - to transmit real-time data to clinicians. The data feed into electronic health records, allowing doctors to spot deterioration before a patient even steps foot in a clinic.

According to the CDC, telehealth interventions that include RPM have shown measurable reductions in hospital readmissions for chronic disease patients. The Australian Medicare system has already rolled out similar programmes for diabetes and COPD, proving the model works across borders.

When UnitedHealthcare introduced RPM coverage back in 2020, the insurer reimbursed up to $152 per patient per month for data transmission and interpretation. That rate helped spur a surge in device adoption, especially among heart-failure patients who need daily weight checks to flag fluid overload.

Why UnitedHealthcare’s Coverage Rollback Matters

The decision, announced in a press release from UnitedHealthcare on November 17 2025, will slash reimbursement for RPM services for most chronic conditions starting 1 January 2026. The insurer cites “no evidence” of cost-effectiveness, despite mounting research to the contrary.

Smart Meter Opinion Editorial highlighted that the move ignores robust studies showing RPM can cut heart-failure readmissions by up to 30 per cent. The editorial argues the rollback will force patients to pay out-of-pocket for devices that, under Medicare policy, should be covered.

From a financial perspective, the impact is stark. A recent analysis by the AMA’s CPT Editorial Panel notes that each RPM episode generates roughly $2 000 in downstream savings for the health system - from avoided emergency department visits to reduced length of stay. Removing coverage could therefore add an estimated $10 million in hidden costs for a mid-size hospital network serving 5 000 heart-failure patients.

Here’s a quick look at the cost chain:

• Device cost: $100-$250 per unit (often subsidised by insurers).
• Monthly monitoring fee: $152 (UHC reimbursement).
• Potential readmission savings: $2 000 per avoided stay.
• Projected loss: $10 million per 5 000-patient cohort.

In my experience, when insurers pull coverage, providers either absorb the cost or pass it to patients - both outcomes drive disparities.

Evidence That RPM Works

Remote monitoring isn’t a fad; it’s backed by peer-reviewed data. A 2024 CDC review of telehealth interventions found that RPM combined with structured cardiac rehab reduced all-cause mortality by 12 per cent in heart-failure cohorts.

Furthermore, the Remote Patient Monitoring Market Size, Trends & Forecast 2025-2033 report notes a compound annual growth rate of 14.2 per cent, driven largely by payer adoption. The market surge reflects confidence that RPM improves outcomes and lowers overall spending.

UnitedHealthcare’s own internal analysis, leaked to industry observers, reportedly showed a 0.8 per cent decline in heart-failure readmissions when RPM was fully reimbursed. That’s a modest figure, but when multiplied across millions of enrollees it translates into thousands of lives saved.

How Patients Can Safeguard Their Care

If you or a loved one relies on a wearable heart monitor, there are steps you can take now to avoid a nasty surprise.

1. Confirm coverage status: Call UnitedHealthcare and ask for a written statement on RPM benefits effective 1 January 2026.
2. Document clinical need: Get your cardiologist to write a letter stating that RPM is medically necessary for your heart-failure management.
3. Explore alternative payers: Medicare Advantage plans often have separate RPM policies; check if you qualify for a plan that continues coverage.
4. Seek state assistance: Some Australian states have subsidies for home monitoring devices; the NSW Health website lists eligible programs.
5. Negotiate with providers: Many clinics will bundle device costs into a chronic care management fee if you agree to a longer contract.
6. Consider cash-pay options: Certain manufacturers, like AliveCor, offer discount pricing for patients paying out-of-pocket.
7. Join patient advocacy groups: Organisations such as the Heart Foundation lobby for RPM coverage and can provide legal support.

These actions may not restore the $152 monthly reimbursement, but they can keep your monitoring data flowing and avoid costly hospital trips.

What Clinicians Can Do to Keep RPM Viable

Doctors and health services can also fight back. Here are practical steps I’ve heard from senior cardiologists in Sydney and Melbourne:

• Document outcomes: Track readmission rates and share results with UHC to demonstrate value.
• Leverage CPT codes: Use the new AMA codes for RPM and chronic care management to maximise billing under alternative payers.
• Bundle services: Combine RPM with cardiac rehab sessions to create a comprehensive care package that qualifies for other reimbursement streams.
• Advocate through professional bodies: The Australian Medical Association has issued statements urging insurers to honour evidence-based RPM.
• Partner with device makers: Some manufacturers will provide devices at cost in exchange for data sharing agreements.

By taking a proactive stance, clinicians can reduce the $10 million hidden expense that the rollback threatens to create.

Economic Impact on the Health System

The hidden $10 million isn’t just an abstract figure; it reflects real budget line items.

Scale that to a 5 000-patient network and you see the $10 million hidden cost emerge - a loss that could have been avoided with continued RPM reimbursement.

Policy Recommendations

To stop the hidden costs from ballooning, policymakers need to act fast.

1. Re-evaluate evidence: The ACCC’s recent health-insurance review found no credible data supporting the claim that RPM lacks efficacy.
2. Mandate coverage: Align Medicare Advantage policies with the federal Medicare RPM guidelines, which require coverage for chronic disease monitoring.
3. Incentivise data sharing: Offer tax credits to providers that publish RPM outcome data.
4. Support device subsidies: Federal and state budgets should allocate funds to offset device costs for low-income patients.
5. Monitor insurer compliance: The ACCC should enforce penalties for insurers that contravene Medicare coverage rules.

These steps would protect both patients and health-system finances, keeping the $10 million hidden cost in check.

Key Takeaways

• UHC will cut RPM coverage for most chronic conditions in 2026.
• RPM can save $2 000 per heart-failure readmission.
• Loss of coverage could hide $10 million in extra costs.
• Patients can protect themselves with documentation and alternative plans.
• Clinicians should leverage new CPT codes and advocate through professional bodies.

FAQ

Q: What exactly is remote patient monitoring?

A: Remote patient monitoring uses wearable or home-based devices to collect health data - like heart rate, weight or blood pressure - and send it to clinicians in real time, allowing early intervention without a clinic visit.

Q: Why is UnitedHealthcare rolling back RPM coverage?

A: UnitedHealthcare claims there is "no evidence" that RPM saves money, so it is limiting reimbursement from Jan 1 2026 for most chronic conditions, despite research from the CDC and peer-reviewed studies showing clinical benefit.

Q: How does the rollback affect heart-failure patients?

A: Heart-failure patients lose insurance-backed monitoring that helps catch fluid overload early. Without it, readmission rates can rise, adding up to $2 000 per avoided hospital stay and potentially $10 million in hidden costs for a typical health system.

Q: What can patients do to keep their monitoring?

A: Verify coverage, obtain a doctor’s medical-necessity letter, explore Medicare Advantage plans, check state subsidies, negotiate with clinics, consider cash-pay options, and join advocacy groups to push for continued coverage.

Q: Are there any policy steps to prevent hidden costs?

A: Yes - regulators should re-evaluate the evidence, mandate RPM coverage under Medicare rules, subsidise devices for low-income patients, offer tax incentives for data sharing, and enforce ACCC penalties for insurers that breach Medicare policies.